共 30 条
- [23] Results of the EICESS-92 study:: Two randomized trials of Ewing's sarcoma treatment -: Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) : 4385 - 4393
- [24] Imetelstat Is Effective Treatment for Patients With Intermediate-2 or High-Risk Myelofibrosis Who Have Relapsed on or Are Refractory to Janus Kinase Inhibitor Therapy: Results of a Phase 2 Randomized Study of Two Dose Levels [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 14 - 15
- [28] A prospective, randomized comparison of two doses of combination alkyating agents (AA) as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes (LN): Preliminary results of CALGB 9082/SWOG 9114/NCIC MA-13. [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 21B - 21B
- [29] Randomized phase II trial comparing two strategies in high-risk rectal cancer (RC): Chemoradiation (CRT) followed by total mesorectal excision (TME) and adjuvant chemotherapy (CT) or induction CT followed by CRT and TME-Preliminary results of the multicenter GCR-3 study [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
- [30] Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : 2457 - 2465